@article {Kelly2020.04.01.20049585, author = {Claire E Kelly and Deanne K Thompson and Sila Genc and Jian Chen and Joseph YM Yang and Chris Adamson and Richard Beare and Marc L Seal and Lex W Doyle and Jeanie LY Cheong and Peter J Anderson}, title = {Long-term development of white matter fibre density and morphology up to 13 years after preterm birth}, elocation-id = {2020.04.01.20049585}, year = {2020}, doi = {10.1101/2020.04.01.20049585}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background It is well documented that infants born very preterm (VP) are at risk of brain injury and altered brain development in the neonatal period, however there is a lack of long-term, longitudinal studies on the effects of VP birth on white matter development over childhood. Most previous studies were based on voxel-averaged, non-fibre-specific diffusion magnetic resonance imaging (MRI) measures, such as fractional anisotropy. In contrast, the novel diffusion MRI analysis framework, fixel-based analysis (FBA), enables whole-brain analysis of microstructural and macrostructural properties of individual fibre populations at a sub-voxel level. We applied FBA to investigate the long-term implications of VP birth and associated perinatal risk factors on fibre development in childhood and adolescence.Methods Diffusion images were acquired for a cohort of VP (born \<30 weeks{\textquoteright} gestation) and full-term (FT, >=37 weeks{\textquoteright} gestation) children at two ages: mean (SD) 7.6 (0.2) years (n=138 VP and 32 FT children) and 13.3 (0.4) years (n=130 VP and 45 FT children). 103 VP and 21 FT children had images at both ages for longitudinal analysis. At every fixel (individual fibre population within an image voxel) across the white matter, we compared FBA metrics (fibre density (FD), cross-section (FC) and a combination of these properties (FDC)) between VP and FT groups cross-sectionally at each age, and longitudinally between ages. We also examined associations between perinatal risk factors and FBA metrics in the VP group.Results Compared with FT children, VP children had lower FD, FC and FDC throughout the white matter, particularly in the corpus callosum, tapetum, inferior fronto-occipital fasciculus, fornix and cingulum at ages 7 and 13 years, as well as the motor pathways at age 13 years. VP children also had slower FDC development in the corpus callosum and corticospinal tract between ages 7 and 13 years compared with FT children. Within VP children, earlier gestational age at birth, lower birth weight z-score, and neonatal brain abnormalities were associated with lower FD, FC and FDC throughout the white matter at both ages.Conclusions VP birth and concomitant perinatal risk factors are associated with fibre tract-specific alterations to axonal development in childhood and adolescence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Australian National Health and Medical Research Council (NHMRC; Centre for Research Excellence 546519, 1060733 and 1153176; Project Grant 237117, 491209 and 1066555; Senior Research Fellowship 1081288 to PJA; Investigator Grant 1176077 to PJA; Career Development Fellowship 1085754 to DKT and 1141354 to JLYC, and; Early Career Fellowship 1012236 to DKT), the Murdoch Children{\textquoteright}s Research Institute, the Royal Children{\textquoteright}s Hospital, the Royal Children{\textquoteright}s Hospital Foundation (RCH1000 to JYMY), the Department of Paediatrics at the University of Melbourne, and the Victorian Government{\textquoteright}s Operational Infrastructure Support Program. The funding organisations/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data analysed during the current study are available from the corresponding author on reasonable request and completion of a data sharing agreement. The data are not publicly available due to ethical restrictions.}, URL = {https://www.medrxiv.org/content/early/2020/04/06/2020.04.01.20049585}, eprint = {https://www.medrxiv.org/content/early/2020/04/06/2020.04.01.20049585.full.pdf}, journal = {medRxiv} }